Theodore James Jr. Washburn - Feb 14, 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Principal Accounting Officer
Signature
/s/ William Cook, as attorney-in-fact for Theodore James Jr. Washburn
Stock symbol
AGIO
Transactions as of
Feb 14, 2022
Transactions value $
-$19,624
Form type
4
Date filed
2/16/2022, 04:00 PM
Previous filing
Feb 14, 2022
Next filing
Feb 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +360 +11.79% $0.00 3.41K Feb 14, 2022 Direct F1, F2
transaction AGIO Common stock Tax liability -$3.87K -127 -3.72% $30.50 3.29K Feb 14, 2022 Direct
transaction AGIO Common stock Sale -$15.8K -504 -15.34% $31.25 2.78K Feb 14, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock units Options Exercise $0 -360 -50% $0.00 360 Feb 14, 2022 Common stock 360 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 Includes 34 shares purchased through the Company's employee stock purchase plan.
F3 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F4 The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.